The Food and Drug Administration (FDA) carried out an inspection at CSL Plasma, Inc. in Douglas on March 5, focusing on blood and blood products, according to data available on the FDA’s website.
The resulting report concluded that CSL Plasma, Inc. was not required to make any changes to its management operations.
The FDA regularly inspects facilities nationwide to assess whether workplaces and their products adhere to FDA-regulated laws and regulations intended to promote public health. Outcomes from these inspections are publicly released.
The organization’s website states that the FDA is a federal agency chiefly responsible for overseeing the safety and quality of the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products.
Information in this article was obtained from the U.S. Food and Drug Administration. The source data can be found here.
